...
首页> 外文期刊>Journal of Molecular Biology >High-resolution structure of HLA-A*0201 in complex with a tumour-specificantigenic peptide encoded by the MAGE-A4 gene
【24h】

High-resolution structure of HLA-A*0201 in complex with a tumour-specificantigenic peptide encoded by the MAGE-A4 gene

机译:HLA-A * 0201与MAGE-A4基因编码的肿瘤特异性抗原肽复合的高分辨率结构

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The heterotrimeric complex of the human major histocompatibity complex (MHC) molecule HLA-A*0201, beta (2)-microglobulin and the decameric peptide GVYDGREHTV derived from the melanoma antigen (MAGE-A4 protein has been determined by X-ray crystallography at 1.4 Angstrom resolution. MAGE-A4 belongs to a family of genes that are specifically expressed in a variety of tumours. MAGE-A4-derived peptides are presented by MHC molecules at the cell surface to cytotoxic T-lymphocytes. As the HLAA*0201:MAGE-A4 complex occurs only on tumour cells, it is considered to be an appropriate target for immunotherapy. The structure presented here reveals potential epitopes specific to the complex and indicates which peptide residues could be recognised by T-cell receptors. In addition, as the structure could be refined anisotropically, it was possible to describe the movements of the bound peptide in more detail.
机译:人类主要组织相容性复合物(MHC)分子HLA-A * 0201,β(2)-微球蛋白和源自黑素瘤抗原的十聚体肽GVYDGREHTV的异三聚体复合物(MAGE-A4蛋白已通过X射线晶体学在1.4埃分辨率。MAGE-A4属于在多种肿瘤中特异性表达的基因家族。MAGE-A4衍生的肽由MHC分子在细胞表面呈递给细胞毒性T淋巴细胞。作为HLAA * 0201:MAGE -A4复合物仅出现在肿瘤细胞上,被认为是免疫治疗的合适靶点,此处显示的结构揭示了该复合物特有的潜在表位,并指出了哪些肽残基可以被T细胞受体识别。由于可以各向异性地精制其结构,因此可以更详细地描述结合肽的运动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号